Feds Reclassify CBD Meds

Cannabis now has a foot in the door to becoming federally legal. Yesterday the US Drug Enforcement Agency (DEA) announced that nonsynthetic cannabis-derived medicine, with approval from the Food and Drug Administration, is no longer considered a Schedule 1 substance, which is the most restrictive class.

You are unauthorized to view this page.